Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Haematologica ; 95(7): 1183-90, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20410183

RESUMEN

BACKGROUND: Hemorrhagic cystitis is a common cause of morbidity after allogeneic stem cell transplantation, frequently associated with BK virus infection. We hypothesized that patients with positive BK viruria before unrelated or mismatched related donor allogeneic hematopoietic stem cell transplantation have a higher incidence of hemorrhagic cystitis. DESIGN AND METHODS: To test this hypothesis, we prospectively studied 209 patients (median age 49 years, range 19-71) with hematologic malignancies who received bone marrow (n=78), peripheral blood (n=108) or umbilical cord blood (n=23) allogeneic hematopoietic stem cell transplantation after myeloablative (n=110) or reduced intensity conditioning (n=99). Donors were unrelated (n=201) or haploidentical related (n=8). RESULTS: Twenty-five patients developed hemorrhagic cystitis. Pre-transplant BK viruria detected by quantitative PCR was positive in 96 patients. The one-year cumulative incidence of hemorrhagic cystitis was 16% in the PCR-positive group versus 9% in the PCR-negative group (P=0.1). The use of umbilical cord blood or a haploidentical donor was the only significant predictor of the incidence of hemorrhagic cystitis on univariate analysis. There was also a trend for a higher incidence after myeloablative conditioning. Multivariate analysis showed that patients who had a positive PCR pre-transplant and received haploidentical or cord blood grafts with myeloablative conditioning had a significantly higher risk of developing hemorrhagic cystitis (58%) than all other recipients (7%, P<0.001). CONCLUSIONS: Hemorrhagic cystitis is the result of a complex interaction of donor type, preparative regimen intensity, and BK viruria.


Asunto(s)
Virus BK , Cistitis/etiología , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Infecciones por Polyomavirus/complicaciones , Infecciones Tumorales por Virus/complicaciones , Adulto , Anciano , Cistitis/patología , Femenino , Neoplasias Hematológicas/complicaciones , Neoplasias Hematológicas/terapia , Hemorragia , Humanos , Masculino , Persona de Mediana Edad , Infecciones por Polyomavirus/etiología , Donantes de Tejidos , Acondicionamiento Pretrasplante/efectos adversos , Acondicionamiento Pretrasplante/métodos , Trasplante Homólogo , Infecciones Tumorales por Virus/etiología , Adulto Joven
2.
Regul Pept ; 112(1-3): 161-6, 2003 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-12667638

RESUMEN

Adrenomedullin (ADM) is a vasoactive and natriuretic peptide. While it is known that ADM is increased in failing human ventricles, the expression of ADM in human ventricular allografts remains unknown. The present study was designed to investigate tissue localization and intensity of ADM expression in ventricular biopsy specimens and to characterize ventricular ADM in human cardiac allografts. Thirty-three post-transplant endomyocardial biopsy specimens were examined immunohistochemically. The average score (range: 0-4) of ADM immunoreactivity (IR) was 2.4+/-0.9 (mean+/-standard deviation). Right ventricular (RV) systolic pressure was significantly increased with high ADM-IR (p=0.048) and the ADM-IR positively associated with myocyte size (r(2)=0.23, p=0.010). In contrast, ADM-IR was not associated with systemic blood pressure, serum creatinine, cyclosporine concentration, cardiac fibrosis, or allograft rejection. The present study shows that ADM-IR is present in human ventricular endomyocardium after transplantation, and ADM-IR is associated with the magnitude of RV pressure and myocyte size, suggesting an important role for ventricular ADM in the counteraction against overload as well as in the progress of myocyte hypertrophy after heart transplantation.


Asunto(s)
Cardiomegalia/etiología , Trasplante de Corazón/efectos adversos , Ventrículos Cardíacos/química , Péptidos/fisiología , Adolescente , Adrenomedulina , Adulto , Anciano , Biopsia , Presión Sanguínea , Cardiomegalia/metabolismo , Cardiomegalia/patología , Tamaño de la Célula , Ciclosporina/farmacología , Femenino , Rechazo de Injerto/metabolismo , Rechazo de Injerto/patología , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Miocardio/patología , Miocitos Cardíacos/fisiología , Péptidos/análisis , Péptidos/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA